Characteristics and outcomes among vaccinated lung transplant patients with breakthrough COVID-19.
Srinivas BollineniLuke D MahanPatrick DuncanManish R MohankaAdrian LawrenceJohn JoernsIrina TimofteFernando TorresRicardo M La HozCorey D KershawLance S TeradaVaidehi KazaAmit BangaPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2022)
In this cohort of vaccinated LT patients who developed breakthrough COVID-19, the clinical course, risk of complications, and outcomes trended better than unvaccinated patients. However, universal involvement of the allograft demonstrates the continued vulnerability of these patients to significant sequelae from COVID-19. Future studies may evaluate the incremental protection of vaccination after the completion of the third dose of mRNA vaccines among LT patients.